HSIC Stock Analysis: Buy, Sell, or Hold?
HSIC - Henry Schein Inc
$86.51
0.76 (0.89%)
▲
5d:
+2.25%
30d:
+0.09%
90d:
+17.02%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When HSIC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HSIC shows positive signals but monitor for confirmation. Market pricing in 2.2% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: HSIC shows positive signals but monitor for confirmation. Market pricing in 2.2% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$114.68
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$71.21
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSIC is currently trading at $86.51, which is considered slightly high relative to its 30-day fair value range of $84.22 to $86.80. The stock's valuation (Forward PE: 14.7) is in line with its historical norms (13.7). At these levels, the market is pricing in 2.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSIC is in a strong uptrend. The price is approaching resistance at $87.73. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSIC is in a strong uptrend. The price is approaching resistance at $87.73. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$84.22 -
$86.80
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.4%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($89.31)
- NEUTRAL: Market pricing in 2.2% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$84.22 -
$86.80
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$83.19
Resistance Level
$87.73
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.65
Wall Street Target
$89.31
(+3.2%)
Revenue Growth (YoY)
6.3%
Earnings Growth (YoY)
4.5%
Profit Margin
2.9%
Valuation Premium vs History
+2.2% premium
PE vs Historical
14.7 vs 13.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.2%
(market-implied from PE analysis)
1-Year Target
$88.41
(+2%)
2-Year Target
$90.36
(+4%)
3-Year Target
$92.35
(+7%)
3-Yr Target (if PE normalizes)
(PE: 15→14)
PE COMPRESSION
$86.37
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 10.5%)
$165.19
(+91%)
Base:
(SPY PE: 14.6, Growth: 10.5%)
$116.73
(+35%)
Bear:
(PE: 12.5, Growth: 10.5%)
$99.22
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 25.91 | Current EPS (TTM): $3.31
Bull Case
$168.29
(+95%)
Analyst growth 78.4%, PE expands to 28.5
Base Case
$152.99
(+77%)
Market implied 78.4%, PE stable at 25.9
Bear Case
$58.31
(-33%)
Severe decline -20.0%, PE contracts to 22.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 04, 2026 1:35 AM ET
Data refreshes hourly during market hours. Next update: 2:35 AM
Data refreshes hourly during market hours. Next update: 2:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSIC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-30
Thomas C Popeck
SELL
1355 shares
2026-03-19
Kurt P Kuehn
SELL
2844 shares
2026-03-10
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$945 | 54 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$357 | 58 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$252 | 57 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced HSIC Option Strategies
Professional options setups generated by AI based on today's HSIC price and gamma walls.
